Skip to main content
. Author manuscript; available in PMC: 2014 Nov 13.
Published in final edited form as: BJU Int. 2011 Jan 18;108(9):1492–1496. doi: 10.1111/j.1464-410X.2010.10015.x

TABLE 4.

Relative odds for ZPC associated with NS

Unadjusted OR (95% CI) Adjusted OR* (95% CI)
Continence at 1 month
 UNS 1.16 (0.52–2.61) 0.73 (0.30–1.77)
 BNS 1.32 (0.62–2.81) 0.74 (0.31–1.75)
Continence at 3 months
 UNS 1.11 (0.52–2.34) 0.79 (0.35–1.79)
 BNS 1.16 (0.58–2.34) 0.68 (0.31–1.52)
Continence at 12 months
 UNS 1.43 (0.48–4.26) 0.65 (0.19–2.18)
 BNS 1.47 (0.53–4.04) 0.45 (0.14–1.47)
*

Adjusted for age, IIEF-5 score, prostate weight, BMI, and surgeon learning curve. AUAss, PSA level and clinical stage were not independently associated with continence in multivariable analysis and were thus excluded from the model.